On Sunday, April 20th 2025, starting 8:30am GMT, there will be maintenance work that will involve the website being unavailable during parts of the day. We apologize for any inconvenience this may cause and appreciate your understanding.
We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Criteria for diagnosis of AILD
- Autoimmune Hepatitis (AIH)
- Spectrum of AIH in 2008
- Differential diagnosis: AIH
- Drugs inducing an AIH-like syndrome
- Diagnosis of Wilson disease Leipzig score
- Steps in management of AIH
- Simplified criteria for diagnosis of AIH
- When to question initiation of AIH treatment
- Screening before IST for AIH
- Indication for AIH treatment
- AIH: response to immunosuppressive therapy
- Treatment regiments for adults
- Standard therapy : AIH
- AIH: preventative measures while on treatment
- Monitoring required during IST for AIH
- AIH: remission following therapy
- Remission following IST withdrawal
- AIH: maintenance therapy with Azathioprine
- Treatment failure
- Primary & secondary sclerosing cholangitis
- Potential pathogenesis: sclerosing cholangitis
- Magnetic Resonance Cholangiography
- Role of ERCP in PSC
- PSC: Presenting Features
- Ulcerative colitis: link to PSC
- PSC with Inflammatory Bowel Disease (IBD)
- Survival IBD vs. IBD+PSC
- Causes of death in 45 patients: PSC
- RCT: Ursodeoxycholic acid - PSC
- Why medical therapy fails in PSC?
- Recurrent AILD after OLT
- Primary Biliary Cirrhosis (PBC)
- PBC- physical presentation
- Typical presentation of PBC in 2009
- Meta analysis: RCT in UDCA for PBC
- Liver transplant
- Longterm survival in early PBC
- Survival in PBC +/- Biochemical response
- Survival according to PHG score
- PBS: natural history
- Treatment response and histological change
- Complications of PBC
- What is the drive and the trigger?
- PBC cases in first degree relatives
- PBC: genome wide analysis
- The genetic web of autoimmunity
- Acknowledgments
Topics Covered
- Diagnosis of Autoimmune Liver Disease (AILD)
- Diagnosis of Autoimmune Hepatitis (AIH)
- Steps in management of AIH
- AIH treatment
- Response to immunosuppressive therapy in AIH
- Monitoring during IST for AIH
- Remission following therapy in AIH
- Presenting features of primary & secondary Sclerosing Cholangitis (PSC)
- Ulcerative colitis: link to PSC
- PSC with Inflammatory Bowel Disease (IBD)
- Causes of death in PSC
- PSC treatment
- Medical therapy failure in PSC
- Typical presentation of Primary Biliary Cirrhosis (PBC)
- Liver transplant in PBC vs. PSC
- Survival in PBC
- Treatment response and histological change in PBC
- Complications of PBC
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Heathcote, J. (2011, January 30). Immune-mediated liver disease [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved April 15, 2025, from https://doi.org/10.69645/KUSD9543.Export Citation (RIS)
Publication History
- Published on January 30, 2011
Financial Disclosures
- Dr. Jenny Heathcote has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.